类风湿关节炎患者急性心肌梗死后的短期与长期死亡率趋势:全国队列研究
该研究分析英格兰和威尔士2005至2019年784,091例急性心肌梗死住院成人(其中6,047例有类风湿关节炎诊断),比较两组不同时间点全因死亡风险。调整后30天死亡率无显著差异,但1年、5年及研究终点全因死亡风险在类风湿关节炎患者中显著升高;心血管死亡风险在5年及研究终点也显著升高。结论提示类风湿关节炎患者心梗后长期死亡负担增加,并非由住院期间心梗治疗质量差异驱动。
要点
- 类风湿关节炎患者心梗后30天全因死亡率与无类风湿关节炎者无显著差异。
- 类风湿关节炎患者心梗后1年、5年及研究终点全因死亡风险显著更高。
- 心血管死亡风险在5年及研究终点显著升高,30天和1年无显著差异。
核心结论
- 类风湿关节炎患者急性心肌梗死后长期全因死亡风险显著升高,但住院期间心梗治疗质量无 meaningful 差异。
研究设计与样本
- 基于英格兰和威尔士2005至2019年784,091例急性心肌梗死住院成人(其中6,047例有类风湿关节炎诊断)的全国队列研究,数据来自Myocardial Ischaemia National Audit Project登记库,链接死亡登记和住院统计,采用Cox回归比较不同时间点全因死亡风险。
主要发现
- 调整后30天全因死亡率两组无显著差异(aHR 1.09,95%CI 0.99-1.19;P=0.075)。
- 1年全因死亡风险显著升高(aHR 1.14,95%CI 1.07-1.21),5年(aHR 1.28,95%CI 1.23-1.33)及研究终点(aHR 1.31,95%CI 1.26-1.36)均显著升高(均P<0.001)。
- 心血管死亡风险30天或1年无显著差异(aHR 1.08,95%CI 1.00-1.17;P=0.058),5年(aHR 1.15,95%CI 1.08-1.23;P<0.001)及研究终点(aHR 1.18,95%CI 1.11-1.24;P<0.001)显著升高。
临床怎么用
- 类风湿关节炎患者心梗后应关注长期死亡风险增加,尤其超过1年后,需加强长期随访和合并症管理。
- 住院期间心梗治疗质量并非类风湿关节炎患者心梗后死亡负担的主要驱动因素,提示应重视疾病进展和治疗并发症的长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We investigated whether a diagnosis of rheumatoid arthritis (RA) affects the quality of inpatient acute myocardial infarction (AMI) care and long-term mortality post-AMI. METHODS: We analyzed data from 784,091 adults, 6,047 with a diagnosis of RA, from England and Wales hospitalized with AMI between 2005 and 2019 from the Myocardial Ischaemia National Audit Project registry, linked with Office for National Statistics mortality data and hospital episode statistics. Cox regression models were used to compare risk of all-cause mortality at different time points according to the presence of RA. RESULTS: There was no difference in adjusted 30-day mortality between groups (adjusted hazard ratio [aHR] 1.09, 95% confidence interval [CI] 0.99-1.19; P = 0.075). Beyond this, at 1 year (aHR 1.14, 95% CI 1.07-1.21), 5 years, (aHR 1.28, 95% CI 1.23-1.33), and to the end of the study period (aHR 1.31, 95% CI 1.26-1.36), the risk of all-cause mortality was significantly higher in patients with RA (all P < 0.001). Risk of cardiovascular mortality was not significantly different at 30 days or 1 year (aHR 1.08, 95% CI 1.00-1.17; P = 0.058), but it was at 5 years (aHR 1.15, 95% CI 1.08-1.23; P < 0.001) and to the study endpoint post-AMI (aHR 1.18, 95% CI 1.11-1.24; P < 0.001). CONCLUSION: We found no meaningful disparities in inpatient care according to the presence of RA; however, those with RA have elevated long-term all-cause mortality post-AMI. Our findings suggest that the mortality burden of RA post-AMI is not driven by the quality of AMI care during admission and is likely driven by the progressive nature of the comorbidities and the complications of treatments associated with RA.
引用
- Butler M, Weight N, Rashid M, et al. Temporal Trends and Short- and Long-Term Mortality of People With Acute Myocardial Infarction and Rheumatoid Arthritis: A Nationwide Cohort Study. Arthritis Care Res (Hoboken). 2026. PMID: 41392517. doi:10.1002/acr.70009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。